Skip to main content
Equibles
CCCC $3.17 +0.32%
CCCC logo
CCCC · C4 Therapeutics, Inc.
Track CCCC — free

Use CCCC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CCCC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.17 +0.01 (+0.32%) At close · Oct 21
Russell 2000 member Rebalance outlook locked
Market Cap
$389.99M
Shares
123.03M
Volume · Oct 21 2.19M Avg daily vol (3M) 2.36M
All webcasts

Earnings call · FY2026 Q1

C4 Therapeutics, Inc. (CCCC) Q1 2026 Earnings Call

Concluded May 26, 2026
May 26, 2026 0 turns
Period
FY2026 Q1
Runtime
—
Sources
3 artifacts
Revenue $6.15M -15% YoY
Diluted EPS -$0.20
Net income -$25.13M
Open full screen Slides 23 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. slides, 8-K earnings release, 10-Q stay in one workspace.

Research coverage

3 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Presentation 23 slides 8-K earnings release Filed May 12, 2026 10-Q report Filed May 12, 2026 Company webcastOpen the original investor-relations page

Quarter detail

How the reported period landed and where the business moved.

Capital returned

Buybacks
$200,000
Full-screen source Call document

CCCC alerts

C4 Therapeutics, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →